The Siberian Scientific Medical Journal / Key word: , chronic myeloid leukemia
CLINICAL MEDICINE
CHRONIC MYELOID LEUKEMIA: EPIDEMIOLOGY AND FIFTEENTH YEARS OF THERAPY IN THE NOVOSIBIRSK REGION
Lyamkina A.S., Maslova L.M., Naumenko O.V., Melnichenko E.V., Obgolts Yu.N., Loginova A.B., Daragan E.V., Nechunaeva I.N., Vorontsova E.V., Shpagina L.A., Yudanov A.V., Khalzov K.V., Pospelova T.I.
QUALITY OF LIFE IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS (REVIEW)
Davydkin I.L., Popelnyuk N.S., Naumova K.V., Mordvinova E.V., Stepanova T.Yu., Krivova S.P., Rogozina A.A., Kuzmina T.P.
TELOMERES AND TELOMERASE ACTIVITY IN CHRONIC MYELOID LEUKEMIA (REVIEW)
PATHOMORPHOLOGICAL ANALYSIS OF TREPANOBIOPTATES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOCYTIC LEUKEMIA: ASSESSMENT OF THE PROGNOSTIC VALUE OF MYELOFIBROSIS WHEN COMPARED WITH CLINICAL DATA
Dolgikh T.Yu., Vinogradova E.V., Kapustina V.I., Senchukova S.R.
Prevalence of myelofibrosis in chronic myeloid leukemia, multiple myeloma and chronic lymphocytic leukemia in different phases of diseases
The results of 12 years treatment of patients in late chronic phase of chronic myeloid leukemia by tyrosine kinase inhibitors after failure IFN-α
Lazareva O.V., Turkina A.G., Gusarova G.A., Chelysheva E.Yu., Zakharova E.S., Shukhov O.A., Bykova A.V., Goryacheva S.R., Kolosheinova T.I., Ivanova T.V., Tishchenko I.A., Kulikov S.M.
Long term results of combined treatment with imatinib and interferon in patients with the newly diagnosed chronic myeloid leukemia in chronic phase
Vinogradova O.Yu., Turkina A.G., Chelysheva E.Yu., Gusarova G.A., Kolosheinova T.I., Kolosova L.Yu., Goryacheva S.R., Vakhrusheva M.V., Khoroshko N.D.
Tactics of therapy in chronic myeloid leukemia during pregnancy. Clinical case
Chelysheva E.Yu., Turkina A.G., Polushkina E.S., Shmakov R.G.
The case of chronic myeloproliferative disorder with combination of a bcr/abl translocation and Jak2 V617F mutation
Gusarova G.A., Semenova E.A., Sokolova M.A., Bykova A.V., Turkina A.G.
Long-term results of therapy by dasatinib and features analysis of the pleural effusion course in patients at late chronic phase of chronic myeloid leukemia after imatinib treatment failure
Abdullaev A.O., Chelysheva E.Yu., Turkina A.G., Lazareva O.V., Kuznetsov S.V., Ivanova T.V., Gusarova G.A., Goryacheva S.R., Vorontsova A.V., Vinogradova O.Yu., Bykova A.V., Shukhov O.A.
